Clinical Trials Sponsored by Prim. Priv. Doz. Dr. Daniel Cejka

Total 6 results

Prim. Priv. Doz. Dr. Daniel Cejka

Not yet recruiting

Effect of Changes in Dialysate Bicarbonate on Serum Calcification Propensity and Calciprotein Particles in Hemodialysis Patients (D-Bic-T50-HD)

End Stage Renal Disease
Prim. Priv. Doz. Dr. Daniel Cejka
Amgen

Completed

A Study to Investigate the Influence of PTH-lowering by Etelcalcetide (Parsabiv®) on the Calcification Propensity of Serum in Dialysis Patients

End Stage Renal Disease

Austria
Prim. Priv. Doz. Dr. Daniel Cejka
Medice Arzneimittel Pütter GmbH & Co KG

Withdrawn

The Effect of Sodium Bicarbonate (Nephrotrans®) on Calcification Propensity of Serum in Kidney Transplant Recipients

Kidney Transplant; Complications

Austria
Prim. Priv. Doz. Dr. Daniel Cejka
Vifor Fresenius Medical Care Renal Pharma

Completed

The Effect of Phosphate Lowering Using Sucroferric Oxyhydroxide (PA21) on Calcification Propensity of Serum

Endstage Renal Disease

Austria
Priv.-Doz. Dr. J. Schattenberg

Completed

Hepatic Inflammation and Physical Performance in Patients With NASH (HELP)

Non-alcoholic Fatty Liver Disease

Germany
Priv.-Doz. Dr. med. Joachim Rom

Completed

Phase I/II Study of Pazopanib and Cyclophosphamide in Patients With Platinum-resistant Recurrent Ovarian Cancer

Epithelial Ovarian Cancer

Germany

3

Subscribe